Published in Women's Health Weekly, November 28th, 2002
"We remain committed to our mission to develop and maintain our technical and market leadership in providing treatment to recurring stroke patients with cardiac sources of stroke," stated NMT Medical President and CEO John E. Ahern. "While we are disappointed with the panel's recommendation to not approve our PMA submission for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.